glp 1 compounded tirzepatide GLP-1 & GIP Compounded Tirzepatide (GLP-1/GIP)

Results will be submitted for publication in an international peer-reviewed scientific journal

GLP-1 Patch does not contain synthetic GLP-1 and is not a GLP-1 agonist drug

The increasingly popular obesity and diabetes drugs known as glucagon-like peptide-1 receptor agonists do not seem to worsen suicidality despite previous concerns, according to recent data published in BMJ.Case reports that linked GLP-1s to suicidality have raised regulatory concerns and left many wondering if these medications are harming the patients they intend to help, Laurent Azoulay, PhD, a

GLP-1 medications are changing how people think about weight loss and how they actually lose weight, driving changes in views about obesity care among health systems and providers and affecting the broader US economy. These drugs hold the potential to help address what continues to be an increasing obesity problem in the US. A 2024 []